Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
3.720
-0.190 (-4.86%)
At close: Jan 30, 2026, 4:00 PM EST
3.650
-0.070 (-1.88%)
After-hours: Jan 30, 2026, 6:54 PM EST
LIXT Employees
Lixte Biotechnology Holdings had 2 employees as of December 31, 2024. The number of employees decreased by 2 or -50.00% compared to the previous year.
Employees
2
Change (1Y)
-2
Growth (1Y)
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$2,066,844
Market Cap
32.41M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 2 | -2 | -50.00% | 2 | 0 |
| Dec 31, 2023 | 4 | 0 | - | 3 | 1 |
| Dec 31, 2022 | 4 | 0 | - | 3 | 1 |
| Dec 31, 2021 | 4 | 0 | - | 3 | 1 |
| Dec 31, 2020 | 4 | 3 | 300.00% | 3 | 1 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Kyntra Bio | 225 |
| Cue Biopharma | 41 |
| Werewolf Therapeutics | 39 |
| AN2 Therapeutics | 22 |
| TuHURA Biosciences | 19 |
| Outlook Therapeutics | 17 |
| Skye Bioscience | 16 |
| Reviva Pharmaceuticals Holdings | 14 |
LIXT News
- 11 days ago - DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE - GlobeNewsWire
- 12 days ago - LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29 - GlobeNewsWire
- 5 weeks ago - LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial - GlobeNewsWire
- 7 weeks ago - LIXTE's Strategy Comes Into Focus: Building an Oncology Platform Around Complementary Modalities - Accesswire
- 2 months ago - LIXTE Levels Up From PP2A Innovation to Multi-Modal Oncology - Accesswire
- 2 months ago - LIXTE Steps Into a Key Role in the Rise of Treatment Amplifiers - Accesswire
- 2 months ago - LIXTE Biotechnology Acquires Liora Technologies' Proprietary Proton Therapy Platform for Cancer Treatment - GlobeNewsWire
- 3 months ago - LIXTE Biotechnology Holdings to Present at the Spartan Capital Investor Conference 2025, November 3 - GlobeNewsWire